OPRM1 Asn40Asp predicts response to naltrexone treatment: a haplotype-based approach (Q37185125)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q30505567)
(Q109580310)
(P304) 383-393
(P433) 3
(P478) 33
(P577) Tuesday, November 25, 2008
(P921) (Q409587)
(P1433) (Q4713331)
(P1476) "OPRM1 Asn40Asp predicts response to naltrexone treatment: a haplotype-based approach" (language: en)
(P2093) Gabor Oroszi
Raymond F Anton
Stephanie O'Malley
Robert Swift
David Couper
Qiaoping Yuan
(P2860) (Q33330500)
(Q24645469)
(Q35012142)
(Q38311454)
(Q38407349)
(Q35189955)
(Q28278645)
(Q36285452)
(Q36145129)
(Q28250678)
(Q35908744)
(Q38336108)
(Q27860955)
(Q29547566)
(Q35566297)
(Q35024267)
(Q27860500)
(Q34641459)
(Q28574561)
(Q31532158)
(Q33679584)
(Q24320057)
(Q36726539)
(Q34241680)
(Q40392922)
(Q40566502)
(Q40743899)
(Q40794878)
(Q44347504)
(Q41775034)
(Q44335036)
(Q44023429)
(Q44351470)
(Q44350222)
(Q44344781)
(Q44342768)
(Q44483802)
(Q44341917)
(Q44340730)
(Q43829059)
(Q43719684)
(Q48738393)
(Q43621127)
(Q44333907)
(Q44352947)
(Q44352794)
(Q44337884)
(Q74618454)
(Q79484297)
(Q70426053)
(Q77347366)
other details
description scientific article

External Links